PMID- 24833633 OWN - NLM STAT- MEDLINE DCOM- 20151203 LR - 20181217 IS - 1758-1001 (Electronic) IS - 0004-5632 (Linking) VI - 52 IP - Pt 2 DP - 2015 Mar TI - Insulin resistance and brain-derived neurotrophic factor levels in chronic kidney disease. PG - 213-9 LID - 10.1177/0004563214533514 [doi] AB - INTRODUCTION: Insulin resistance is a frequent abnormality in chronic kidney disease (CKD) appearing in early stages. Factors known to promote insulin resistance in CKD patients include disorders of ion and acid-base equilibrium and circulating uremia toxins. Recent research has focused on the central nervous system as the source of the brain-derived neurotrophic factor (BDNF). The aim of our work was to study plasma BDNF concentrations in stage 3 and 4 CKD patients in relationship with insulin resistance and distribution of adipose tissue. METHOD: Plasma BDNF concentrations were measured in a study group of 31 patients, including a subgroup of 20 non-diabetic subjects. Additionally dual-energy X-ray absorptiometry (DXA) was performed. Homeostatic model assessment of insulin resistance (HOMA-IR) and homeostatic model assessment of B-cell function (HOMA-beta) indices were calculated. RESULTS: Two separate analyses were performed. In the first analysis performed in all 31 CKD patients, there were no correlations between BDNF and: body mass index (BMI), android, gynoid fat distribution, HOMA-IR and HOMA-beta. In the second analysis performed in 20 CKD patients without diabetes, BDNF was negatively related to gynoid fat (Rs = -0.47, P = 0.034) and women revealed significantly lower levels of BDNF than men (P = 0.046). Normotensive patients disclosed significantly higher BDNF levels than hypertensive patients in the whole CKD group (P = 0.039) and in the non-diabetic subgroup (P = 0.028). No correlations between BDNF and eGFR were found. CONCLUSIONS: Female sex and arterial hypertension are associated with lower BDNF plasma concentration in CKD patients. CI - (c) The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav. FAU - Marchelek-Mysliwiec, Malgorzata AU - Marchelek-Mysliwiec M AD - Department of Nephrology, Transplantology and Internal Diseases, Pomeranian Medical University, Poland malgorzata.marchelek@gmail.com. FAU - Cichocka, Ewa AU - Cichocka E AD - Department of Nephrology, Transplantology and Internal Diseases, Pomeranian Medical University, Poland. FAU - Dziedziejko, Violetta AU - Dziedziejko V AD - Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Poland. FAU - Dutkiewicz, Gra Z Yna AU - Dutkiewicz GZ AD - Department of Nephrology, Transplantology and Internal Diseases, Pomeranian Medical University, Poland. FAU - Stepniewska, Joanna AU - Stepniewska J AD - Department of Nephrology, Transplantology and Internal Diseases, Pomeranian Medical University, Poland. FAU - Safranow, Krzysztof AU - Safranow K AD - Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Poland. FAU - Budkowska, Marta AU - Budkowska M AD - Department of Medical Analytics, Pomeranian Medical University, Poland. FAU - Salata, Daria AU - Salata D AD - Department of Medical Analytics, Pomeranian Medical University, Poland. FAU - Syrenicz, Anhelli AU - Syrenicz A AD - Department of Endocrinology, Pomeranian Medical University, Poland. FAU - Machalinski, Boguslaw AU - Machalinski B AD - Department of Pathology, Pomeranian Medical University, Poland. FAU - Ciechanowski, Kazimierz AU - Ciechanowski K AD - Department of Nephrology, Transplantology and Internal Diseases, Pomeranian Medical University, Poland. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140515 PL - England TA - Ann Clin Biochem JT - Annals of clinical biochemistry JID - 0324055 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Insulin) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - Adiposity MH - Body Mass Index MH - Brain-Derived Neurotrophic Factor/*blood MH - Diabetes Mellitus, Type 2/complications MH - Diabetic Nephropathies/complications/epidemiology/metabolism/physiopathology MH - Down-Regulation MH - Female MH - Humans MH - Hypertension/complications MH - Insulin/blood/metabolism MH - *Insulin Resistance MH - Insulin Secretion MH - Insulin-Secreting Cells/metabolism MH - Intra-Abdominal Fat/metabolism MH - Male MH - Middle Aged MH - Poland/epidemiology MH - Renal Insufficiency, Chronic/complications/epidemiology/*metabolism/physiopathology MH - Risk Factors MH - Severity of Illness Index MH - Sex Characteristics OTO - NOTNLM OT - Renal disease OT - clinical studies OT - endocrinology EDAT- 2014/05/17 06:00 MHDA- 2015/12/15 06:00 CRDT- 2014/05/17 06:00 PHST- 2014/05/17 06:00 [entrez] PHST- 2014/05/17 06:00 [pubmed] PHST- 2015/12/15 06:00 [medline] AID - 0004563214533514 [pii] AID - 10.1177/0004563214533514 [doi] PST - ppublish SO - Ann Clin Biochem. 2015 Mar;52(Pt 2):213-9. doi: 10.1177/0004563214533514. Epub 2014 May 15.